BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33246337)

  • 1. The IBD-disk Is a Reliable Tool to Assess the Daily-life Burden of Patients with Inflammatory Bowel Disease.
    Tadbiri S; Nachury M; Bouhnik Y; Serrero M; Hébuterne X; Roblin X; Kirchgesner J; Bouguen G; Franchimont D; Savoye G; Buisson A; Louis E; Nancey S; ABitbol V; Reimund JM; DeWit O; Vuitton L; Matthieu N; Peyrin-Biroulet L; Gilletta C; Allez M; Viennot S; Trang-Poisson C; Dib N; Brixi H; Boualit M; Plastaras L; Boivineau L; Fumery M; Caillo L; Laharie D; Amiot A;
    J Crohns Colitis; 2021 May; 15(5):766-773. PubMed ID: 33246337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory bowel disease (IBD)-disk accurately predicts the daily life burden and parallels disease activity in patients with IBD.
    Singh A; Gupta YK; Dhaliwal AS; Kahlon BK; Bansal V; Mahajan R; Mehta V; Singh D; Kaur R; Bansal N; Midha V; Sood A
    Intest Res; 2023 Jul; 21(3):375-384. PubMed ID: 36245342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VALIDation of the IBD-Disk Instrument for Assessing Disability in Inflammatory Bowel Diseases in a French Cohort: The VALIDate Study.
    Le Berre C; Flamant M; Bouguen G; Siproudhis L; Dewitte M; Dib N; Cesbron-Metivier E; Goronflot T; Hanf M; Gourraud PA; Kerdreux E; Poinas A; Bourreille A; Trang-Poisson C
    J Crohns Colitis; 2020 Nov; 14(11):1512-1523. PubMed ID: 32417910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IBD-Disk as a tool estimating the prevalence of inflammatory bowel disease-related disability and associated influencing factors in Saudi Arabia: A cross-sectional study.
    Meeralam Y; Al-Zanbagi AB; Al Saedi M; Alharthi W; Sabbahi HA; Alhejaili T; Shariff MK
    Saudi J Gastroenterol; 2023; 29(5):309-315. PubMed ID: 37787349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of IBD-related disability: a cross-sectional survey from the GETAID.
    Tannoury J; Nachury M; Martins C; Serrero M; Filippi J; Roblin X; Bourrier A; Bouguen G; Franchimont D; Savoye G; Buisson A; Louis E; Nancey S; Abitbol V; Reimund JM; DeWitt O; Vuitton L; Mathieu N; Peyrin-Biroulet L; Gilletta C; Allez M; Viennot S; Trang-Poisson C; Laharie D; Amiot A;
    Aliment Pharmacol Ther; 2021 May; 53(10):1098-1107. PubMed ID: 33817819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent Validation of a Self-Report Version of the IBD Disability Index (IBDDI) in a Population-Based Cohort of IBD Patients.
    Shafer LA; Walker JR; Chhibba T; Ivekovic M; Singh H; Targownik LE; Peyrin-Biroulet L; Gower-Rousseau C; Sarter H; Bernstein CN
    Inflamm Bowel Dis; 2018 Mar; 24(4):766-774. PubMed ID: 29554260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Inflammatory Bowel Disease-Disk Tool for Assessing Disability in Inflammatory Bowel Disease Patients: Validation of the Greek Version.
    Katsoula A; Axiaris G; Mpitouli A; Palatianou M; Christidou A; Dimitriadis N; Nakos A; Pastras P; Kourkoulis P; Karatzas P; Moutzoukis M; Zlatinoudis C; Philippidis A; Kourikou A; Kokkotis G; Gklavas A; Machaira A; Mantaka A; Talimtzi P; Anagnostopoulou E; Koutroubakis IE; Papaconstantinou I; Bamias G; Manolakopoulos S; Mathou N; Paraskeva K; Protopappas A; Tsironi E; Katsanos KH; Christodoulou DK; Papatheodoridis G; Michalopoulos G; Theocharis G; Triantos C; Pachiadakis I; Soufleris K; Viazis N; Mantzaris GJ; Tribonias G; Tzouvala M; Theodoropoulou A; Karmiris K; Zampeli E; Michopoulos S; Haidich AB; Giouleme O
    J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disability and quality of life before and during the COVID-19 outbreak: A cross-sectional study in inflammatory bowel disease patients.
    Azzam NA; Aljebreen A; Almuhareb A; Almadi MA
    Saudi J Gastroenterol; 2020; 26(5):256-262. PubMed ID: 32415045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol of a multicentric prospective cohort study for the VALIDation of the IBD-disk instrument for assessing disability in inflammatory bowel diseases: the VALIDate study.
    Le Berre C; Bourreille A; Flamant M; Bouguen G; Siproudhis L; Dewitte M; Dib N; Cesbron-Metivier E; Goronflot T; Hanf M; Gourraud PA; Kerdreux E; Poinas A; Trang-Poisson C
    BMC Gastroenterol; 2020 Apr; 20(1):110. PubMed ID: 32299390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Multicenter Study of Patient Acceptability of the IBD Disk Tool and Patient-Reported Disabilities.
    Sharma N; Savelkoul E; Disney B; Shah A; De Silva S; Pattni S; Iacucci M; Cooney R; Ghosh S
    Dig Dis Sci; 2022 Feb; 67(2):457-462. PubMed ID: 33721160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients' real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID group.
    Nachury M; Bouhnik Y; Serrero M; Filippi J; Roblin X; Kirchgesner J; Bouguen G; Franchimont D; Savoye G; Buisson A; Louis E; Nancey S; Abitbol V; Reimund JM; DeWit O; Vuitton L; Matthieu N; Peyrin-Biroulet L; Gilletta C; Tadbiri S; Allez M; Viennot S; Bourreille A; Laharie D; Amiot A;
    Dig Liver Dis; 2021 Apr; 53(4):434-441. PubMed ID: 33187920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective validation study of the International Classification of Functioning, Disability and Health score in Crohn's disease and ulcerative colitis.
    Leong RW; Huang T; Ko Y; Jeon A; Chang J; Kohler F; Kariyawasam V
    J Crohns Colitis; 2014 Oct; 8(10):1237-45. PubMed ID: 24662396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a Simple 0 to 10 Numerical Score (IBD-10) of Patient-reported Inflammatory Bowel Disease Activity for Routine Clinical Use.
    Subramanian S; Asher R; Weston W; Rimmer M; McConville A; Malin A; Jackson R; Collins P; Probert C; Dibb M; Rhodes JM
    Inflamm Bowel Dis; 2016 Aug; 22(8):1902-7. PubMed ID: 27243590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a rapid, generic measure of disease control from the patient's perspective: the IBD-control questionnaire.
    Bodger K; Ormerod C; Shackcloth D; Harrison M;
    Gut; 2014 Jul; 63(7):1092-102. PubMed ID: 24107590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases.
    Ghosh S; Louis E; Beaugerie L; Bossuyt P; Bouguen G; Bourreille A; Ferrante M; Franchimont D; Frost K; Hebuterne X; Marshall JK; OʼShea C; Rosenfeld G; Williams C; Peyrin-Biroulet L
    Inflamm Bowel Dis; 2017 Mar; 23(3):333-340. PubMed ID: 28146002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of inflammatory bowel disease in the Australian general practice population: A cross-sectional study.
    Busingye D; Pollack A; Chidwick K
    PLoS One; 2021; 16(5):e0252458. PubMed ID: 34043730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Patient-Reported Outcome-Based Evaluation (PROBE) of Quality of Life in Patients With Inflammatory Bowel Disease.
    Barnes EL; Kappelman MD; Long MD; Evon DM; Martin CF; Sandler RS
    Am J Gastroenterol; 2019 Apr; 114(4):640-647. PubMed ID: 30848727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life, work productivity and costs related to patients with inflammatory bowel disease in Austria.
    Walter E; Hausberger SC; Groß E; Siebert U
    J Med Econ; 2020 Oct; 23(10):1061-1071. PubMed ID: 32713223
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.